<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02708966</url>
  </required_header>
  <id_info>
    <org_study_id>GSIG</org_study_id>
    <nct_id>NCT02708966</nct_id>
  </id_info>
  <brief_title>Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.</brief_title>
  <official_title>Effect of the Administration of Gymnema Sylvestre on Glycemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guadalajara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guadalajara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prediabetes (PD) was defined as an state in which glucose levels are above normal but not&#xD;
      enough to meet criteria for the diagnosis of type 2 diabetes (T2D). PD can be presented as&#xD;
      impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and glycated hemoglobin A1c&#xD;
      (A1C) altered. The International Diabetes Federation (IDF) reported that in 2013 the&#xD;
      prevalence of IGT was 6.9% which is equivalent to approximately 316 million individuals with&#xD;
      IGT, it is expected that by 2035 this number will increase to 417 million people affected.&#xD;
      Many hypoglycemic effects attributed to Gymnema sylvestre have been reported, including:&#xD;
      increase of insulin secretion, regeneration of pancreatic islet cells, increased glucose&#xD;
      utilization in various ways and inhibition of glucose uptake in the intestine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The target is to evaluate the effect of the administration of Gymnema Sylvestre on glycemic&#xD;
      control, insulin secretion and insulin sensibility on patients with IGT. The investigators&#xD;
      will conduct a double-blind trial, randomized, placebo control group, each group 12 female&#xD;
      and male patients, between 30 and 59 years old with IGT (2-h values in the oral glucose&#xD;
      tolerance test, OGTT) from 140 mg / dL to 199 mg / dL), Body Mass Index (BMI) from 25 to 34.9&#xD;
      kg / m2. Randomization will determine who will receive the intervention during the 9-week&#xD;
      trial (Gymnema Sylvestre capsules, 300 mg 2 times daily with the first bite of breakfast and&#xD;
      dinner or homologated placebo capsules). The clinical findings and laboratory tests include a&#xD;
      metabolic profile and biosafety, which will be made at baseline and at week 9. Body weight,&#xD;
      body fat, BMI and blood pressure will be determined during the initial and final visit.&#xD;
      Adverse events and adherence to treatment will be documented. Statistical analysis:&#xD;
      Mann-Whitney U test, Wilcoxon and Fisher exact test. It is considered with significance at p&#xD;
      &lt;0.05.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">September 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting Plasma Glucose</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>2-hour Post Load Plasma Glucose (2-h PG)</measure>
    <time_frame>90 days</time_frame>
    <description>The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycated Hemoglobin A1c (A1C)</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by high-performance liquid chromatography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Insulin Secretion (Insulinogenic Index)</measure>
    <time_frame>90 days</time_frame>
    <description>Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose) after intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First Phase of Insulin Secretion</measure>
    <time_frame>90 days</time_frame>
    <description>First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0') after intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Sensitivity (Matsuda Index)</measure>
    <time_frame>90 days</time_frame>
    <description>Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)] after intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area Under the Curve of Glucose</measure>
    <time_frame>90 days</time_frame>
    <description>Area under the curve of glucose was obtained using the trapezoidal integration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Curve of Insulin</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention area under the curve of insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight (BW)</measure>
    <time_frame>12 weeks</time_frame>
    <description>The weight was measured at baseline, week 4, week 8 and week 12 with a bioimpedance balance and the entered values reflect the weight at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>12 weeks</time_frame>
    <description>The Body Mass index was calculated at baseline and at week 12 with the Quetelet index and the entered values reflect the body mass index at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist Circumference (WC)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Waist circumference was evaluated at baseline and at week 12 with a flexible tape and the entered values reflects the waist circumference measure at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure (SBP)</measure>
    <time_frame>12 weeks</time_frame>
    <description>The Systolic Blood Pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure (DBP)</measure>
    <time_frame>12 weeks</time_frame>
    <description>The Diastolic blood pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoprotein Cholesterol</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Density Lipoprotein</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Very Low Density Lipoprotein</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
    <time_frame>90 days</time_frame>
    <description>After intervention by spectrophotometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Impaired Glucose Tolerance</condition>
  <arm_group>
    <arm_group_label>Gymnema Sylvestre</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with IGT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients with IGT</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gymnema Sylvestre</intervention_name>
    <description>Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
    <arm_group_label>Gymnema Sylvestre</arm_group_label>
    <other_name>Gurmar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Calcined Magnesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI: 25.0-34.99 kg / m2.&#xD;
&#xD;
          -  Diagnosis of IGT (2h-OGTT Values between 140mg / dl and 199mg / dl.)&#xD;
&#xD;
          -  Written informed consent.&#xD;
&#xD;
          -  body weight stable over the last 3 months.&#xD;
&#xD;
          -  Women in follicular phase of the menstrual cycle (days 3 to 8 of the cycle) at the&#xD;
             time of laboratory tests.&#xD;
&#xD;
          -  Women who are not contemplated get pregnant within the next 6 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women pregnant or breastfeeding.&#xD;
&#xD;
          -  Physical or mental disability that makes it impossible to perform the intervention.&#xD;
&#xD;
          -  Diagnosis of hypertension or heart failure.&#xD;
&#xD;
          -  Smokers.&#xD;
&#xD;
          -  Untreated thyroid disease.&#xD;
&#xD;
          -  Consumption of oral agents or other medications or supplements with proven properties&#xD;
             that modify the behavior of glucose and lipids (oral hypoglycemic agents, insulin,&#xD;
             lipid-lowering).&#xD;
&#xD;
          -  Diagnosis of liver disease or elevation twice of the upper normal value of liver&#xD;
             enzymes.&#xD;
&#xD;
          -  Diagnosis of renal disease or creatinine &gt; 1.5 mg / dl.&#xD;
&#xD;
          -  Diagnosis of Type 2 Diabetes Mellitus (T2DM) Fasting glucose ≥ 126 mg / dL and/or&#xD;
             2h-OGTT ≥ 200 mg / dL and/or A1C ≥ 6.5%.&#xD;
&#xD;
          -  Total Cholesterol ≥ 280 mg/dL.&#xD;
&#xD;
          -  Triglycerides ≥ 300 mg/dL.&#xD;
&#xD;
          -  Known allergy to calcined magnesia or Gymnema sylvestre.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esperanza Martínez-Abundis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44340</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>March 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2016</study_first_posted>
  <results_first_submitted>July 20, 2020</results_first_submitted>
  <results_first_submitted_qc>November 12, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 18, 2020</results_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guadalajara</investigator_affiliation>
    <investigator_full_name>Esperanza Martínez-Abundis</investigator_full_name>
    <investigator_title>PHD</investigator_title>
  </responsible_party>
  <keyword>Gymnema Sylvestre</keyword>
  <keyword>Glycemic control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 18, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT02708966/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Gymnema Sylvestre</title>
          <description>Patients with impaired glucose tolerance (IGT)&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gymnema Sylvestre</title>
          <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" spread="10"/>
                    <measurement group_id="B2" value="44" spread="7"/>
                    <measurement group_id="B3" value="45" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Weight (BW)</title>
          <description>The BW was evaluated after an overnight fast, through a bioimpedance digital scale results are reported in kilograms with a decimal.</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.6" spread="11.9"/>
                    <measurement group_id="B2" value="79.1" spread="16.8"/>
                    <measurement group_id="B3" value="79.3" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>The BMI was calculated by the square of the body height, and is universally expressed in units of kg/m2, resulting from mass in kilograms and height in metres.</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.1" spread="3.7"/>
                    <measurement group_id="B2" value="29.8" spread="5.2"/>
                    <measurement group_id="B3" value="30.4" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist circumference (WC)</title>
          <description>The WC was evaluated after an overnight fast with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.3" spread="6.9"/>
                    <measurement group_id="B2" value="98.8" spread="9.8"/>
                    <measurement group_id="B3" value="98" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic blood pressure (SBP)</title>
          <description>The SBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of SBP. The value was expressed on mmHg.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117" spread="12"/>
                    <measurement group_id="B2" value="119" spread="12"/>
                    <measurement group_id="B3" value="118" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic blood pressure (DBP)</title>
          <description>The DBP was evaluated with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of DBP. The value was expressed on mmHg.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77" spread="13"/>
                    <measurement group_id="B2" value="77" spread="8"/>
                    <measurement group_id="B3" value="77" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Triglycerides (TGs)</title>
          <description>The blood sample for determining of TGs, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.8" spread="1.3"/>
                    <measurement group_id="B2" value="1.5" spread="0.7"/>
                    <measurement group_id="B3" value="1.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total cholesterol (TC)</title>
          <description>The blood sample for determining of TC, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.1" spread="0.1"/>
                    <measurement group_id="B2" value="5.2" spread="0.9"/>
                    <measurement group_id="B3" value="5.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>high-density lipoprotein cholesterol (HDL-C)</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.0" spread="0.1"/>
                    <measurement group_id="B2" value="0.9" spread="0.3"/>
                    <measurement group_id="B3" value="0.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Low-density lipoprotein cholesterol (LDL-C)</title>
          <description>The blood sample for determining of LDL-C, was taken after an overnight fast and was calculated by Friedewald formula. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.5" spread="0.8"/>
                    <measurement group_id="B2" value="3.5" spread="0.5"/>
                    <measurement group_id="B3" value="3.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Very-low density lipoprotein (VLDL)</title>
          <description>The blood sample for determining the VLDL, was taken after an overnight fast and was calculated as triglycerides/5 . The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.4" spread="0.3"/>
                    <measurement group_id="B2" value="0.3" spread="0.1"/>
                    <measurement group_id="B3" value="0.3" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting plasma glucose (FPG)</title>
          <description>The blood sample for determining of FPG, was taken after an overnight fast and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.9" spread="0.4"/>
                    <measurement group_id="B2" value="5.6" spread="0.4"/>
                    <measurement group_id="B3" value="5.8" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>2-hour postload plasma glucose (2-h PG)</title>
          <description>The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.1" spread="1.2"/>
                    <measurement group_id="B2" value="8.6" spread="0.8"/>
                    <measurement group_id="B3" value="8.9" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glycated hemoglobin A1c</title>
          <units>Percent of glycated hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.8" spread="0.3"/>
                    <measurement group_id="B2" value="5.6" spread="0.2"/>
                    <measurement group_id="B3" value="5.7" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Creatinine</title>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.5" spread="17.7"/>
                    <measurement group_id="B2" value="70.8" spread="26.5"/>
                    <measurement group_id="B3" value="70.8" spread="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Area under the curve of glucose (AUCG)</title>
          <description>The estimation for AUCG was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed mmol/L/min.</description>
          <units>mmol/L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1157" spread="147"/>
                    <measurement group_id="B2" value="1078" spread="137"/>
                    <measurement group_id="B3" value="1120" spread="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Area under the curve of insulin (AUCI)</title>
          <description>The estimation for AUCI was calculated from parameters obtained during the 2 hours oral glucose tolerant test (OGTT) with 75 g dextrose by trapezoidal integration. The value was expressed on pmol/L/min.</description>
          <units>pmol/L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68,348" spread="20,329"/>
                    <measurement group_id="B2" value="63,544" spread="28,041"/>
                    <measurement group_id="B3" value="65946" spread="24188"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total insulin secretion</title>
          <description>Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose).</description>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.56" spread="0.20"/>
                    <measurement group_id="B2" value="0.54" spread="0.22"/>
                    <measurement group_id="B3" value="0.54" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>First phase of insulin secretion</title>
          <description>First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0').</description>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1297" spread="550"/>
                    <measurement group_id="B2" value="1391" spread="712"/>
                    <measurement group_id="B3" value="1344" spread="627"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin sensitivity</title>
          <description>Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)].</description>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.8" spread="0.8"/>
                    <measurement group_id="B2" value="2.5" spread="1.5"/>
                    <measurement group_id="B3" value="2.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fasting Plasma Glucose</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <population>All participants, including those who dropped out before the end were taken into account for statical analysis (intention to treat).</population>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Plasma Glucose</title>
          <description>After intervention by spectrophotometry</description>
          <population>All participants, including those who dropped out before the end were taken into account for statical analysis (intention to treat).</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.4" spread="11.6"/>
                    <measurement group_id="O2" value="77.7" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>2-hour Post Load Plasma Glucose (2-h PG)</title>
        <description>The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>2-hour Post Load Plasma Glucose (2-h PG)</title>
          <description>The blood sample for determining of 2-h PG, was taken two hours after the ingestion of the drink with 75 g dextrose and was evaluated by spectrophotometry method. The value was expressed on mmol/L.</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.8" spread="1.7"/>
                    <measurement group_id="O2" value="7.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glycated Hemoglobin A1c (A1C)</title>
        <description>After intervention by high-performance liquid chromatography</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Glycated Hemoglobin A1c (A1C)</title>
          <description>After intervention by high-performance liquid chromatography</description>
          <units>Percent of glycated hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="0.4"/>
                    <measurement group_id="O2" value="5.7" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Insulin Secretion (Insulinogenic Index)</title>
        <description>Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose) after intervention.</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Total Insulin Secretion (Insulinogenic Index)</title>
          <description>Total insulin secretion was calculated with the insulinogenic index (ΔABC insulin / ΔABC glucose) after intervention.</description>
          <units>Unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.21"/>
                    <measurement group_id="O2" value="0.49" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>First Phase of Insulin Secretion</title>
        <description>First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0') after intervention.</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>First Phase of Insulin Secretion</title>
          <description>First phase of insulin secretion was estimated using the Stumvoll index (1283+ 1.829 x insulin 30' - 138.7 x glucose 30' + 3.772 x insulin 0') after intervention.</description>
          <units>Unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1399" spread="552"/>
                    <measurement group_id="O2" value="1528" spread="677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity (Matsuda Index)</title>
        <description>Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)] after intervention.</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity (Matsuda Index)</title>
          <description>Insulin sensitivity was calculated with Matsuda index [10,000 / √glucose 0' x insulin 0') (mean glucose oral glucose tolerance test (OGTT) x mean insulin OGTT)] after intervention.</description>
          <units>Unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="1.2"/>
                    <measurement group_id="O2" value="2.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Curve of Glucose</title>
        <description>Area under the curve of glucose was obtained using the trapezoidal integration.</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve of Glucose</title>
          <description>Area under the curve of glucose was obtained using the trapezoidal integration.</description>
          <units>mmol/l/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1075" spread="253"/>
                    <measurement group_id="O2" value="1018" spread="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Curve of Insulin</title>
        <description>After intervention area under the curve of insulin</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve of Insulin</title>
          <description>After intervention area under the curve of insulin</description>
          <units>mmol/l/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56968" spread="20787"/>
                    <measurement group_id="O2" value="53374" spread="20663"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight (BW)</title>
        <description>The weight was measured at baseline, week 4, week 8 and week 12 with a bioimpedance balance and the entered values reflect the weight at week 12</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Body Weight (BW)</title>
          <description>The weight was measured at baseline, week 4, week 8 and week 12 with a bioimpedance balance and the entered values reflect the weight at week 12</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.4" spread="11.6"/>
                    <measurement group_id="O2" value="77.7" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (BMI)</title>
        <description>The Body Mass index was calculated at baseline and at week 12 with the Quetelet index and the entered values reflect the body mass index at week 12</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>The Body Mass index was calculated at baseline and at week 12 with the Quetelet index and the entered values reflect the body mass index at week 12</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.3" spread="3.6"/>
                    <measurement group_id="O2" value="29.3" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Waist Circumference (WC)</title>
        <description>Waist circumference was evaluated at baseline and at week 12 with a flexible tape and the entered values reflects the waist circumference measure at week 12</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Waist Circumference (WC)</title>
          <description>Waist circumference was evaluated at baseline and at week 12 with a flexible tape and the entered values reflects the waist circumference measure at week 12</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.3" spread="7.7"/>
                    <measurement group_id="O2" value="99" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure (SBP)</title>
        <description>The Systolic Blood Pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure (SBP)</title>
          <description>The Systolic Blood Pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120" spread="15"/>
                    <measurement group_id="O2" value="120" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure (DBP)</title>
        <description>The Diastolic blood pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure (DBP)</title>
          <description>The Diastolic blood pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75" spread="10"/>
                    <measurement group_id="O2" value="77" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Cholesterol</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol</title>
          <description>After intervention by spectrophotometry</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="1.2"/>
                    <measurement group_id="O2" value="5.4" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglycerides</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides</title>
          <description>After intervention by spectrophotometry</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.9"/>
                    <measurement group_id="O2" value="1.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Density Lipoprotein Cholesterol</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>High Density Lipoprotein Cholesterol</title>
          <description>After intervention by spectrophotometry</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.2"/>
                    <measurement group_id="O2" value="1.0" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low Density Lipoprotein</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Low Density Lipoprotein</title>
          <description>After intervention by spectrophotometry</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="1.3"/>
                    <measurement group_id="O2" value="3.2" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Very Low Density Lipoprotein</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Very Low Density Lipoprotein</title>
          <description>After intervention by spectrophotometry</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.2"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatinine</title>
        <description>After intervention by spectrophotometry</description>
        <time_frame>90 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Gymnema Sylvestre</title>
            <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
          </group>
        </group_list>
        <measure>
          <title>Creatinine</title>
          <description>After intervention by spectrophotometry</description>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.8" spread="17.6"/>
                    <measurement group_id="O2" value="70.8" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected throughout the 90 days of the study</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Gymnema Sylvestre</title>
          <description>Patients with IGT&#xD;
Gymnema Sylvestre: Gymnema Sylvestre, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Patients with IGT&#xD;
Placebo: Placebo, 300mg capsules 2 times daily with the first bite of breakfast and dinner</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>ANY</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Abdominal distention</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Anorexy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Sweet taste intolerance</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dra. Esperanza Martínez Abundis</name_or_title>
      <organization>Institute of Experimental and Clinical Therapeutics</organization>
      <phone>+52-33-10-58-52-00 ext 34211</phone>
      <email>esperanzamartnezabundi@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

